Abstract: A patient slider device configured to move a patient from a first bed surface to a second bed surface positioned adjacent thereto. The patient slider device includes a frame, a bed engagement assembly and a patient pulling assembly. The bed engagement assembly includes a bumper with the bumper being adjustable relative to the frame. The patient pulling assembly includes a winch assembly, preferably positioned proximate a lower end of the frame, and a sheet engaging clamp assembly. The sheet engaging clamp assembly includes a base member and a locking member structurally configured to clamp a sheet therebetween.

Abstract: The system includes first and second laser illuminators to illuminate a scene, including a target. The pulses of light emitted from the first laser illuminator having a relatively broad spectral linewidth and a relatively long pulse duration compared with pulses of light from the second laser illuminator. A camera system uses a relatively long gate period for receiving returns from the first laser illuminator to obtain a first image of the scene and to use a relatively short gate period together with ranging information of the target to receive returns from the second laser illuminator to obtain a second image of the target that selectively excludes non-target elements within the scene. The second image is used as a template to selectively remove the non-target elements from the first image.

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: A system and method for determining the location of a vehicle when GNSS signals are not available use triangulation between one or two radio transmitters and, respectively, two or one radio receivers mounted on the vehicle. The distance between each radio transmitter and/or each radio receiver can be determined according a phase difference between received radio signals. The radio signals can have the geographical location of the radio transmitter included therein. Utilizing the demodulated geographical location of each radio transmitter and the distance between the radio transmitter and each radio receiver, triangulation can be used to determine the geographical location of the vehicle.

Abstract: A system and method for determining the location of a vehicle when GNSS signals are not available use triangulation between one or two radio transmitters and, respectively, two or one radio receivers mounted on the vehicle. The distance between each radio transmitter and/or each radio receiver can be determined according a phase difference between received radio signals. The radio signals can have the geographical location of the radio transmitter included therein. Utilizing the demodulated geographical location of each radio transmitter and the distance between the radio transmitter and each radio receiver, triangulation can be used to determine the geographical location of the vehicle.

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: A system and method for determining the location of a vehicle when GNSS signals are not available use triangulation between one or two radio transmitters and, respectively, two or one radio receivers mounted on the vehicle. The distance between each radio transmitter and/or each radio receiver can be determined according a phase difference between received radio signals. The radio signals can have the geographical location of the radio transmitter included therein. Utilizing the demodulated geographical location of each radio transmitter and the distance between the radio transmitter and each radio receiver, triangulation can be used to determine the geographical location of the vehicle.

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: In a method of train deceleration, a train computer: (a) causes brakes of the train to be set according to a target deceleration curve, profile, or braking model estimated to decelerate the train from a present speed at a present location to a target speed at a target location; (b) during deceleration of the train according to the target deceleration curve, profile, or braking model of step (a), determines an actual deceleration curve of the train; (c) in response to determining from the actual deceleration curve that the train will overshoot the target speed at the target location, determines another target deceleration curve, profile, or braking model estimated to decelerate the train to the target speed at the target location; and (d) causes the brakes of the train to be set according to the other target deceleration curve, profile or braking model of step (c).

Abstract: In a method of determining the location of a locomotive when GPS signals are not available, triangulation between one or two radio transmitters and, respectively, two or one radio receivers mounted on the train can be used. In the method, the distance between each radio transmitter and each radio receiver can be determined according a number of cycles of the radio signal generated by the radio transmitter that are received/counted by the radio receiver. The radio signal can also have modulated thereon the geographical location of the radio transmitter, which location can be demodulated by the radio receiver. Utilizing the demodulated geographical location of each radio transmitter and the distance between the radio transmitter and each radio receiver, triangulation can be used to determine the geographical location of the train.

Abstract: In a method of train deceleration, a train computer: (a) causes brakes of the train to be set according to a target deceleration curve, profile, or braking model estimated to decelerate the train from a present speed at a present location to a target speed at a target location; (b) during deceleration of the train according to the target deceleration curve, profile, or braking model of step (a), determines an actual deceleration curve of the train; (c) in response to determining from the actual deceleration curve that the train will overshoot the target speed at the target location, determines another target deceleration curve, profile, or braking model estimated to decelerate the train to the target speed at the target location; and (d) causes the brakes of the train to be set according to the other target deceleration curve, profile or braking model of step (c).

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: Apparatus and systems are disclosed for detecting outages in an LED lamp assembly. An example disclosed lamp assembly includes a plurality of LED circuits serially connected together. The LED circuits include an LED, a first resistor and an optocouper. The example disclosed lamp assembly also includes a sense line electrically coupled to one of the LED circuits. The sense line has a first voltage value when all of LEDs in that plurality of LED circuits are operational and a second voltage value when at least one of the LEDs has failed.

Abstract: Antimicrobial metal ion coatings and implants including them. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, rhodium, manganese, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal. The implant may be configured as an implant such as a bone-screw or intramedullary rod-like body configured to receive a treatment cartridge having a coating as described.

Abstract: Apparatus and systems are disclosed for detecting outages in an LED lamp assembly. An example disclosed lamp assembly includes a plurality of LED circuits serially connected together. The LED circuits include an LED, a first resistor and an optocoupler. The example disclosed lamp assembly also includes a sense line electrically coupled to one of the LED circuits. The sense line has a first voltage value when all of LEDs in that plurality of LED circuits are operational and a second voltage value when at least one of the LEDs has failed.

Abstract: Antimicrobial metal ion coatings. In particular, described herein are coatings including an anodic metal (e.g., silver and/or zinc and/or copper) that is co-deposited with a cathodic metal (e.g., palladium, platinum, gold, molybdenum, titanium, iridium, osmium, niobium or rhenium) on a substrate so that the anodic metal is galvanically released as antimicrobial ions when the apparatus is exposed to a bodily fluid. The anodic metal may be at least about 25 percent by volume of the coating, resulting in a network of anodic metal with less than 20% of the anodic metal in the coating fully encapsulated by cathodic metal.

Abstract: A method, apparatus and non-transitory computer medium are provided for obtaining a required frame size for a first compressed data frame to be generated by compressing at least a first data frame of a media file, the first compressed data frame for use by a user equipment in a communications network. The method comprises, responsive to receiving a request for the media file from the user equipment, retrieving at least metadata of the media file. The required frame size for the first compressed data frame is determined based on a size of the at least a first data frame as indicated by the metadata, a compression parameter indicative of a requested compression factor for the at least a first data frame and a biasing factor that acts to reduce the effect of the requested compression factor.

Abstract: A method for treating chemotherapy-induced nausea and vomiting in individuals undergoing chemotherapy and previously treated with, and whom failed to respond to, a 5-HT3 antagonist other than granisetron is described. Individuals who fail to respond to, for example, palonosetron, as evidenced by an inadequate prevention or attenuation of acute or delayed chemotherapy-induced nausea and vomiting, are treated with a semi-solid drug delivery vehicle that provides a sustained release of granisetron.

Abstract: Disclosed herein are methods of enhancing the stability of a sustained pharmaceutical composition comprising an active agent and a polymer and methods of preparing such pharmaceutical compositions with enhanced stability.